Elimination of methadone benefits in the Oregon health plan and its effects on patients

Bret E. Fuller, Traci Rieckmann, Dennis McCarty, Roz Ringor-Carty, Sandy Kennard

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Objectives: This prospective study assessed the impacts of a policy change to Oregon's Medicaid program (Oregon Health Plan; OHP) that eliminated methadone benefits for 60 percent of active methadone patients. Recipients of OHP Standard (expanded Medicaid benefits, which were discontinued after the policy change) self-selected into two groups: those who paid for methadone after the policy change and those who terminated treatment. OHP Plus beneficiaries (traditional Medicaid) did not lose benefits. Methods: A total of 149 patients participated in the study, and interviews were conducted at baseline (time of policy change) and one, three, and 12 months after the policy change. Patients were assessed with the Addiction Severity Index (ASI), Timeline Follow Back assessment, and chart review. Results: Patients who left treatment because they were unable to pay for methadone services showed significant elevations in ASI composite scores for drug and legal problems at baseline and at two and three months after the policy change. The patients who attempted to self-pay experienced significantly more employment problems than the other two groups. The OHP Standard recipients who paid for their methadone treatment over the year were more likely to have additional resources to pay for methadone, be employed, and have stable housing. Conclusions: The elimination of methadone treatment benefits in the OHP had substantial negative impacts for patients with the greatest indicators of need.

Original languageEnglish (US)
Pages (from-to)686-691
Number of pages6
JournalPsychiatric Services
Volume57
Issue number5
DOIs
StatePublished - May 2006

Fingerprint

Methadone
addiction
recipient
Health
health
Medicaid
Group
housing
drug
interview
resources
Therapeutics
Prospective Studies
Interviews
time
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Public Health, Environmental and Occupational Health
  • Health(social science)
  • Health Professions(all)

Cite this

Elimination of methadone benefits in the Oregon health plan and its effects on patients. / Fuller, Bret E.; Rieckmann, Traci; McCarty, Dennis; Ringor-Carty, Roz; Kennard, Sandy.

In: Psychiatric Services, Vol. 57, No. 5, 05.2006, p. 686-691.

Research output: Contribution to journalArticle

Fuller, Bret E. ; Rieckmann, Traci ; McCarty, Dennis ; Ringor-Carty, Roz ; Kennard, Sandy. / Elimination of methadone benefits in the Oregon health plan and its effects on patients. In: Psychiatric Services. 2006 ; Vol. 57, No. 5. pp. 686-691.
@article{a41ec6e93ae24f309a902565c1ee3dc2,
title = "Elimination of methadone benefits in the Oregon health plan and its effects on patients",
abstract = "Objectives: This prospective study assessed the impacts of a policy change to Oregon's Medicaid program (Oregon Health Plan; OHP) that eliminated methadone benefits for 60 percent of active methadone patients. Recipients of OHP Standard (expanded Medicaid benefits, which were discontinued after the policy change) self-selected into two groups: those who paid for methadone after the policy change and those who terminated treatment. OHP Plus beneficiaries (traditional Medicaid) did not lose benefits. Methods: A total of 149 patients participated in the study, and interviews were conducted at baseline (time of policy change) and one, three, and 12 months after the policy change. Patients were assessed with the Addiction Severity Index (ASI), Timeline Follow Back assessment, and chart review. Results: Patients who left treatment because they were unable to pay for methadone services showed significant elevations in ASI composite scores for drug and legal problems at baseline and at two and three months after the policy change. The patients who attempted to self-pay experienced significantly more employment problems than the other two groups. The OHP Standard recipients who paid for their methadone treatment over the year were more likely to have additional resources to pay for methadone, be employed, and have stable housing. Conclusions: The elimination of methadone treatment benefits in the OHP had substantial negative impacts for patients with the greatest indicators of need.",
author = "Fuller, {Bret E.} and Traci Rieckmann and Dennis McCarty and Roz Ringor-Carty and Sandy Kennard",
year = "2006",
month = "5",
doi = "10.1176/appi.ps.57.5.686",
language = "English (US)",
volume = "57",
pages = "686--691",
journal = "Psychiatric Services",
issn = "1075-2730",
publisher = "American Psychiatric Association",
number = "5",

}

TY - JOUR

T1 - Elimination of methadone benefits in the Oregon health plan and its effects on patients

AU - Fuller, Bret E.

AU - Rieckmann, Traci

AU - McCarty, Dennis

AU - Ringor-Carty, Roz

AU - Kennard, Sandy

PY - 2006/5

Y1 - 2006/5

N2 - Objectives: This prospective study assessed the impacts of a policy change to Oregon's Medicaid program (Oregon Health Plan; OHP) that eliminated methadone benefits for 60 percent of active methadone patients. Recipients of OHP Standard (expanded Medicaid benefits, which were discontinued after the policy change) self-selected into two groups: those who paid for methadone after the policy change and those who terminated treatment. OHP Plus beneficiaries (traditional Medicaid) did not lose benefits. Methods: A total of 149 patients participated in the study, and interviews were conducted at baseline (time of policy change) and one, three, and 12 months after the policy change. Patients were assessed with the Addiction Severity Index (ASI), Timeline Follow Back assessment, and chart review. Results: Patients who left treatment because they were unable to pay for methadone services showed significant elevations in ASI composite scores for drug and legal problems at baseline and at two and three months after the policy change. The patients who attempted to self-pay experienced significantly more employment problems than the other two groups. The OHP Standard recipients who paid for their methadone treatment over the year were more likely to have additional resources to pay for methadone, be employed, and have stable housing. Conclusions: The elimination of methadone treatment benefits in the OHP had substantial negative impacts for patients with the greatest indicators of need.

AB - Objectives: This prospective study assessed the impacts of a policy change to Oregon's Medicaid program (Oregon Health Plan; OHP) that eliminated methadone benefits for 60 percent of active methadone patients. Recipients of OHP Standard (expanded Medicaid benefits, which were discontinued after the policy change) self-selected into two groups: those who paid for methadone after the policy change and those who terminated treatment. OHP Plus beneficiaries (traditional Medicaid) did not lose benefits. Methods: A total of 149 patients participated in the study, and interviews were conducted at baseline (time of policy change) and one, three, and 12 months after the policy change. Patients were assessed with the Addiction Severity Index (ASI), Timeline Follow Back assessment, and chart review. Results: Patients who left treatment because they were unable to pay for methadone services showed significant elevations in ASI composite scores for drug and legal problems at baseline and at two and three months after the policy change. The patients who attempted to self-pay experienced significantly more employment problems than the other two groups. The OHP Standard recipients who paid for their methadone treatment over the year were more likely to have additional resources to pay for methadone, be employed, and have stable housing. Conclusions: The elimination of methadone treatment benefits in the OHP had substantial negative impacts for patients with the greatest indicators of need.

UR - http://www.scopus.com/inward/record.url?scp=33646439724&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646439724&partnerID=8YFLogxK

U2 - 10.1176/appi.ps.57.5.686

DO - 10.1176/appi.ps.57.5.686

M3 - Article

C2 - 16675764

AN - SCOPUS:33646439724

VL - 57

SP - 686

EP - 691

JO - Psychiatric Services

JF - Psychiatric Services

SN - 1075-2730

IS - 5

ER -